Pharmacists in Melrose, Massachusetts


30 Pharmacists found in Melrose
male pharmacist

Dr. Matthew Carruth Moen, PHARMD


Pharmacist
50 Tremont St Ste 201, Melrose, MA 02176
617-413-7614    

female pharmacist

Mrs. Nhung Hong Tran, PHARM D.


Pharmacist
897 Main St, Melrose, MA 02176
781-665-1329     781-662-3458

female pharmacist

Paige Marie Demarco, PHARMACIST



585 Lebanon St, Melrose, MA 02176
781-979-3855    



male pharmacist

Robert Stoica, PHARMD


Pharmacist
585 Lebanon St, Melrose, MA 02176
781-979-3000    

female pharmacist

Shilpa Mitesh Patel


Pharmacist
516 Main St # 522, Melrose, MA 02176
781-665-7107     781-662-9357

female pharmacist

Stephanie Ying Mui, RPH


Pharmacist
897 Main St, Melrose, MA 02176
781-665-1329    

female pharmacist

Stephanie Lyn Carvel, PHARMD


Pharmacist
50 Tremont St, Melrose, MA 02176
781-333-6040    

female pharmacist

Suzy Kim, PHARMD.


Pharmacist
884 Main St, Melrose, MA 02176
781-462-2000    

male pharmacist

Tony Quoc Tran, RPH


Pharmacist
897 Main St, Melrose, MA 02176
781-665-1329     781-662-3458

male pharmacist

Dr. Trung Ngoc Tran, PHARM.D.


Pharmacist
897 Main St, Melrose, MA 02176
781-665-1329    

female pharmacist

Veronica Ly


Pharmacist
897 Main St, Melrose, MA 02176
781-665-1329    

male pharmacist

Mr. Victor Paul Fournier, R.PH.


Pharmacist
50 Tremont St, Melrose, MA 02176
781-738-1115    

female pharmacist

Weiyan Feng, PHARMD


Pharmacist
880 Main St, Melrose, MA 02176
781-665-0613    

female pharmacist

Wuju Chun, PHARMD


Pharmacist
585 Lebanon St, Melrose, MA 02176
781-979-3000    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.